Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

The distribution of apolipoprotein E alleles in Scottish perinatal deaths.

Becher JC, Keeling JW, McIntosh N, Wyatt B, Bell J.

J Med Genet. 2006 May;43(5):414-8. Epub 2005 Sep 23.

2.

Distribution of apolipoprotein E alleles in a Scottish healthy newborn population.

Becher JC, Bell JE, McIntosh N, Keeling JW.

Biol Neonate. 2005;88(3):164-7. Epub 2005 Jun 3.

PMID:
15942165
3.

Apolipoprotein E e4 and its prevalence in early childhood death due to sudden infant death syndrome or to recognised causes.

Becher JC, Keeling JW, Bell J, Wyatt B, McIntosh N.

Early Hum Dev. 2008 Aug;84(8):549-54. doi: 10.1016/j.earlhumdev.2008.01.002. Epub 2008 Feb 20.

PMID:
18280677
4.

Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population.

MacLeod MJ, De Lange RP, Breen G, Meiklejohn D, Lemmon H, Clair DS.

Eur J Clin Invest. 2001 Jul;31(7):570-3.

PMID:
11454010
5.

[APOE gene polymorphisms associated with Down syndrome in Colombian populations].

Rengifo L, Gaviria D, Serrano H.

Biomedica. 2012 Jun;32(2):224-32. doi: 10.1590/S0120-41572012000300010. Spanish.

6.

Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage.

Tang J, Zhao J, Zhao Y, Wang S, Chen B, Zeng W.

Surg Neurol. 2003 Nov;60(5):391-6; discussion 396-7.

PMID:
14572957
7.

No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo.

Lendon CL, Han BH, Salimi K, Fagan AM, Behrens MI, Muller MC, Holtzman DM.

Eur J Neurosci. 2000 Jul;12(7):2235-42.

PMID:
10947802
8.

Apolipoprotein E polymorphism and stroke subtypes in an Italian cohort.

Cerrato P, Baima C, Grasso M, Lentini A, Bosco G, Cassader M, Gambino R, Cavallo Perin P, Pagano G, Fornengo P, Imperiale D, Bergamasco B, Bruno G.

Cerebrovasc Dis. 2005;20(4):264-9. Epub 2005 Aug 22.

PMID:
16123547
9.

Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.

Akanji AO, Ohaeri JU, Al-Shammri SN, Fatania HR.

Neuropsychobiology. 2009;60(2):67-72. doi: 10.1159/000236446. Epub 2009 Sep 10.

PMID:
19752580
10.

Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.

Bratosiewicz-Zapart J, Kłoszewska I, Sobów T, Liberski PP.

Arch Immunol Ther Exp (Warsz). 1997;45(2-3):221-2.

PMID:
9597090
11.

Agricultural pesticide exposure and perinatal mortality in central Sudan.

Taha TE, Gray RH.

Bull World Health Organ. 1993;71(3-4):317-21.

12.

Effect of apolipoprotein E polymorphism on renal transplantation.

Cofán F, Cofan M, Rosich E, Campos B, Casals E, Zambon D, Ros E, Oppenheimer F, Campistol JM.

Transplant Proc. 2007 Sep;39(7):2217-8.

PMID:
17889142
13.

The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.

D'Onofrio G, Panza F, Seripa D, Sancarlo D, Paris F, Cascavilla L, Urbano M, Gravina C, Fontana A, Solfrizzi V, Pellegrini F, Pilotto A.

Int J Geriatr Psychiatry. 2011 Oct;26(10):1062-70. doi: 10.1002/gps.2644. Epub 2010 Oct 29.

PMID:
21905100
14.

Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus.

Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, Irving WL; Trent HCV Study Group.

Hepatology. 2002 Aug;36(2):456-63.

PMID:
12143056
15.

Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.

Helisalmi S, Hiltunen M, Valonen P, Mannermaa A, Koivisto AM, Lehtovirta M, Ryynänen M, Soininen H.

J Neurol. 1999 Sep;246(9):821-4.

PMID:
10525981
16.

[Apolipoprotein E genotypes in patients investigated for dementia].

Johannsen P, Jakobsen JK, Jørgensen AL.

Ugeskr Laeger. 1997 Sep 15;159(38):5658-61. Danish.

PMID:
9340872
17.

Apolipoprotein E genotype and outcome in infants with hypoxic-ischemic encephalopathy.

Cotten CM, Goldstein RF, McDonald SA, Goldberg RN, Salhab WA, Carlo WA, Tyson JE, Finer NN, Walsh MC, Ehrenkranz RA, Laptook AR, Guillet R, Schibler K, Van Meurs KP, Poindexter BB, Stoll BJ, O'Shea TM, Duara S, Das A, Higgins RD, Shankaran S; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

Pediatr Res. 2014 Mar;75(3):424-30. doi: 10.1038/pr.2013.235. Epub 2013 Dec 9.

18.

Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort.

Corella D, Portolés O, Arriola L, Chirlaque MD, Barrricarte A, Francés F, Huerta JM, Larrañaga N, Martínez C, Martinez-Camblor P, Molina E, Navarro C, Quirós JR, Rodríguez L, Sánchez MJ, Ros E, Sala N, González CA, Moreno-Iribas C.

J Nutr Biochem. 2011 May;22(5):487-94. doi: 10.1016/j.jnutbio.2010.04.003. Epub 2010 Aug 5.

PMID:
20688498
19.

Association between apolipoprotein E alleles and calcific valvular heart disease.

Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP.

Circulation. 2003 Oct 14;108(15):1804-8. Epub 2003 Oct 6.

PMID:
14530190
20.

Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.

Kamboh MI.

Hum Biol. 1995 Apr;67(2):195-215. Review.

PMID:
7729825

Supplemental Content

Support Center